ClinicalTrials.gg
CompletedNCT05757921Updated Mar 10, 2023

Comparison of Adjunctive Chemomechanical Therapy With Standard Care in Patients With Periodontitis

An interventional study of Perisolv (A) and Standard (B) in Periodontitis, sponsored by Kristianstad University. Completed. Open to participants aged 23 Years and older. Per ClinicalTrials.gov, last updated 2023-03-10.

Sponsored by Kristianstad University · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Registered 11 years 4 months after the study started (first participant enrolled Oct 2011, registered Feb 2023).

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
38
Allocation
Randomized
Ages
23 Years and older
Sex
All
01

Study summary

The goal of the clinical trial is to compare adjunctive chemomechanical therapy with standard care regarding root planning in patients with periodontitis. The primary outcome is to measure pocket depth before and after treatment in the test, and control group respectively

Secondary outcomes:

  • Bleeding on probing
  • Plaque index
  • Quality of life from standardized protocol

The hypothesis is that non- surgical mechanical treatment with chloramines in patients with periodontitis will show a better pocket closure after the treatment.

Read the detailed description

Data from the clinical treatment were registered in patient records. In parallel, clinical data were documented in a study protocol and saved in a safe in accordance with standard operation procedure at the clinic.The protocol with medical records were not opened until the study was completed and only by authorized persons with access to the data in the study such as, principal investigator and statisticians.

Variables used in the study originates from an international working group in periodontology in 2018 (Papapanou PN, et al 2018). In accordance with the working group diagnosis of periodontitis should include pocket depth, bleeding, and bone loss (X-ray). Thus, in this study the primary outcomes were pocket depth and bleeding on probing.

To compare scaling and root planning in periodontitis with an adjunctive application to enhance the standard care; an active comparator (Control group) was compared with an experimental arm (Test group).

Patients were therefore randomized into a test or control group. Inclusion criteria

  • At least four pathological pockets ≥ 5 mm and bleeding on probing Exclusion criteria
  • Diabetes HbA1c >7.0, antibiotics 3 months before treatment, cortisone treatment and if needed prophylactic antibiotics

Patients that participated in the study were consecutively given an ID code. Data was collected and registered in the ordinary patient journal. Journal entry and a research protocol was used with the unique ID number as to prevent breaches of privacy. The dental hygienist performed the treatments and was therfore not blinded. The periodontologists performed the primary and secondary outcomes within the clinical study were both blinded. The code list with the actual treatment was secured in a locked up space, at the clinic. Upon the final appointment the specific arm of treatment was registered by the dental hygienist in the patient journal. To ensure that the data from the study were correctly registered three independent dental nurses were validating the data separately.

All patients were given oral and written information about the study and signed a written informed consent. The patients were informed that they could drop off whenever they wanted without any explanations. The ethical board approved the study.

From a standard operation procedure by good clinical practice and Swedish legislation (The national board of social affairs and health and Health and Medical Care Act), the control group was exposed to mechanical non-surgical treatment in addition with oral hygiene instructions at baseline, 3 months, and 12 months. In the test group the same standard operation procedure was performed with the addition of Perisolv® in all pathological pockets ≥ 4 mm. Perisolv® was added initially and directly after the treatment. At all-time points both primary and secondary outcomes were determined for all pockets. In addition, the instrument Oral Health Impact Profile (OHIP) was used as a measurement of quality of life.

Risk assessments was handled by the safety regulation and quality plan of the clinic.The clinic followed the Swedish legalisation, Health and Medical Care Act with quality assurance. If any adverse events during the treatments the local standard operation procedures ensured reporting to concerned authority in Sweden. Participant not fulfilling the study was reported in the patient journal as not completed and statistically noted as missing data.

Regarding the study's safety plan any adverse event during the treatment code list would be decoded and would be covered by the dental insurance.

From the power analysis 32 individuals were minimum to reach a clinically significant difference at 0.5 mm between the groups with alpha 0.05 and power 80%. The IBM SPSS version 27.0 statistical software package (SPSS Inc., Armonk, NY, USA) for personal computer was used in the statistical analyses. Statistics was calculated as means with standard deviation (SD). Independent t-tests (equal variance not assumed) paired t-test and one-way ANOVA test were used to compare inter and intra-group differences. Non-parametric chi-square test was used for categorical variables. Statistical significance was set with 80 percent at p \< 0.05. Non visits were recorded as missing data in the statistics.

02

Conditions studied

  • Periodontitis

Keywords

  • probing pocket depth
  • bleeding on probing
  • dental plaque
03

In context

Periodontitis

1,242 studies on the registry are indexed under Periodontitis; 304 are open to participants now.

This study's enrollment of 38 is below the median of 44 across 850 interventional studies indexed under Periodontitis.

Browse Periodontitis studies →

Lead sponsor

Kristianstad University is the lead sponsor of 9 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
23 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

Individuals who agree to participate in the study and who also have at least 4 gingival pockets with probing depth ≥5 mm and which at the same time bleed on probing.

Exclusion criteria

-

Exclusion Criteria:

  • Individuals with uncontrolled/difficult diabetes mellitus ( > 7.0)
  • Individuals who need antibiotic prophylaxis
  • Individuals taking medication with Prednisolone.
  • Individuals taking medication that has a known side effect, gingival hyperplasia
  • Individuals who took systemic antibiotics 3 months before the start of the study.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

HbA1c

A blood test of average blood sugar over the past two to three months, given as a percentage or in mmol/mol. 6.5% (48 mmol/mol) or more is the usual threshold for diabetes, normally confirmed by a second test.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Investigator, Outcomes assessor)
Enrollment
38 participants (actual)

Study arms

  • Experimental
    Non-surgical mechanical treatment with Perisolv® (A)

    The test group will receive the following treatment: In the deepened pockets to be treated, Perisolv is initially applied according to the manufacturers recommendation.Then subgingival debridement is performed. This is performed with piezoelectric ultrasound (EMS) while rinsing water and completed with subgingival manual instrumentation. In addition an aliquot of Perisolv was left after final debridement.

    Device: Perisolv (A)

  • Active comparator
    Non-surgical mechanical treatment without Perisolv® (B)

    The control group will receive the following treatment: In the deepened pockets to be treated, subgingival debridement is performed. This is performed with piezoelectric ultrasound (EMS) while rinsing water and completed with subgingival manual instrumentation.

    Other: Standard (B)

Interventions

  • DevicePerisolv (A)

    Intended for cleaning periodontal pockets for both periodontitis and peri-implantitis. Softens degenerative tissue and biofilm before depuration of periodontal pockets. Does not affect healthy tissue.

  • OtherStandard (B)

    Deepened periodontal pockets to be treated are performed by subgingivally debridement. This is performed with piezoelectric ultrasound (EMS) under rinsing water and subgingival debridement with hand instrument.

06

What researchers measure

Primary outcomes

  1. probing pocket depth

    millimeter

    Time frame: baseline

  2. probing pocket depth

    millimeter

    Time frame: 3 months

  3. probing pocket depth

    millimeter

    Time frame: 12 months

Secondary outcomes

  1. bleeding on probing

    percent

    Time frame: baseline

  2. bleeding on probing

    percent

    Time frame: 3 months

  3. bleeding on probing

    percent

    Time frame: 12 months

  4. plaque index

    percent

    Time frame: baseline

  5. plaque index

    percent

    Time frame: 3 months

  6. plaque index

    percent

    Time frame: 12 months

07

Study locations

No study locations are listed for this record.

08

References and documents

Publications

  • Smiley CJ, Tracy SL, Abt E, Michalowicz BS, John MT, Gunsolley J, Cobb CM, Rossmann J, Harrel SK, Forrest JL, Hujoel PP, Noraian KW, Greenwell H, Frantsve-Hawley J, Estrich C, Hanson N. Systematic review and meta-analysis on the nonsurgical treatment of chronic periodontitis by means of scaling and root planing with or without adjuncts. J Am Dent Assoc. 2015 Jul;146(7):508-24.e5. doi: 10.1016/j.adaj.2015.01.028. PubMed 26113099 ↗
  • Ferreira MC, Dias-Pereira AC, Branco-de-Almeida LS, Martins CC, Paiva SM. Impact of periodontal disease on quality of life: a systematic review. J Periodontal Res. 2017 Aug;52(4):651-665. doi: 10.1111/jre.12436. Epub 2017 Feb 8. PubMed 28177120 ↗
  • Citterio F, Gualini G, Chang M, Piccoli GM, Giraudi M, Manavella V, Baima G, Mariani GM, Romano F, Aimetti M. Pocket closure and residual pockets after non-surgical periodontal therapy: A systematic review and meta-analysis. J Clin Periodontol. 2022 Jan;49(1):2-14. doi: 10.1111/jcpe.13547. Epub 2021 Nov 11. PubMed 34517433 ↗
  • Jepsen K, Jepsen S. Antibiotics/antimicrobials: systemic and local administration in the therapy of mild to moderately advanced periodontitis. Periodontol 2000. 2016 Jun;71(1):82-112. doi: 10.1111/prd.12121. PubMed 27045432 ↗
  • Guida A. Mechanism of action of sodium hypochlorite and its effects on dentin. Minerva Stomatol. 2006 Sep;55(9):471-82. English, Italian. PubMed 17146426 ↗
  • Papapanou PN, Sanz M, Buduneli N, Dietrich T, Feres M, Fine DH, Flemmig TF, Garcia R, Giannobile WV, Graziani F, Greenwell H, Herrera D, Kao RT, Kebschull M, Kinane DF, Kirkwood KL, Kocher T, Kornman KS, Kumar PS, Loos BG, Machtei E, Meng H, Mombelli A, Needleman I, Offenbacher S, Seymour GJ, Teles R, Tonetti MS. Periodontitis: Consensus report of workgroup 2 of the 2017 World Workshop on the Classification of Periodontal and Peri-Implant Diseases and Conditions. J Periodontol. 2018 Jun;89 Suppl 1:S173-S182. doi: 10.1002/JPER.17-0721. PubMed 29926951 ↗

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Oct 2011 to primary completion in May 2014, 30 months.

Of 484 non-industry interventional studies with no phase under Periodontitis, half reached primary completion within 15 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 31. This study's 30 months is above that.

Counting every sponsor, half of 498 studies reached it within 15 months; a quarter within 8 and three quarters within 31.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 24, 2023
First posted
Mar 7, 2023
StartActual
Oct 24, 2011
Primary completionActual
May 16, 2014
CompletionActual
May 16, 2014
Last update
Mar 10, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 10, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05757921
Lead sponsor
Kristianstad University
Responsible party
Viveca Wallin Bengtsson (Principle investigator, Kristianstad University) — Principal investigator
First posted
Mar 7, 2023
Start date
Oct 24, 2011
Primary completion
May 16, 2014
Completion
May 16, 2014
Last update
Mar 10, 2023

Study contacts

Ann-Marie AJ Roos Jansaker, Assoc.Prof.
principal investigator · Kristianstad University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion